Cerence Inc. announced a strategic move to repurchase approximately $27 million of its 3.00% Convertible Senior Notes due 2025 at a price of 98.5% of face value, using cash reserves to improve its ...
In the realm of biotech and pharmaceuticals, fundraising often plays a pivotal role in driving innovation and progress. Biotech and pharmaceutical companies, whether private startups or established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback